Theratechnologies, a biopharmaceutical company focused on the development and commercialization of innovative therapies, received funding of $40 million under the terms of its credit agreement with affiliated funds of Marathon Asset Management. This...
Read Story
July 29, 2022, 07:31 AM
|
Theratechnologies, a biopharmaceutical company focused on the development and commercialization of innovative therapies, received a binding commitment with respect to a non-dilutive term loan with an affiliate of Marathon Asset Management for up to...
Read Story
July 18, 2022, 07:39 AM
|